Items where authors include "Bourke, S."
Article
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Sandercock, P., Darbyshire, J., DeMets, D. et al. (2050 more authors) (2024) Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature Communications, 15. 924. ISSN 2041-1723
Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587
Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736
Cabello, M. R., Garcia, S. G., Angulo, L. D. et al. (4 more authors) (2020) Comments on ”A new conformal FDTD for lossy thin panels”. Ieee transactions on antennas and propagation. pp. 7234-7235. ISSN 1558-2221
Tariq, M.A., Everest, F.L.C., Cowley, L.A. et al. (13 more authors) (2019) Temperate bacteriophages from chronic Pseudomonas aeruginosa lung infections show disease-specific changes in host range and modulate antimicrobial susceptibility. mSystems, 4 (4). ISSN 2379-5077
Hoo, Z. orcid.org/0000-0002-7067-3783, Coates, E., Maguire, C. et al. (11 more authors) (2018) Pragmatic criteria to define chronic pseudomonas aeruginosa infection among adults with cystic fibrosis. European Journal of Clinical Microbiology & Infectious Diseases, 37 (11). pp. 2219-2222. ISSN 0934-9723
Cox, M., O'Connor, C., Biggs, K. et al. (17 more authors) (2018) The feasibility of early pulmonary rehabilitation and activity after COPD exacerbations: external pilot randomised controlled trial, qualitative case study and exploratory economic evaluation. Health Technology Assessment, 22 (11). pp. 1-204. ISSN 1366-5278
Hallinan, G., Littlefair, S.P. orcid.org/0000-0001-7221-855X, Cotter, G. et al. (12 more authors) (2015) Magnetospherically driven optical and radio aurorae at the end of the stellar main sequence. Nature, 523 (7562). pp. 568-571. ISSN 0028-0836
McDermott, C.J., Maguire, C., Cooper, C.L. et al. (18 more authors) (2012) Protocol for diaphragm pacing in patients with respiratory muscle weakness due to motor neurone disease (DiPALS): a randomised controlled trial. BMC Neurology, 12. 74. ISSN 1471-2377
Oliver, E., Killen, J., Kiebert, G. et al. (5 more authors) (2001) Treatment pathways, resource use and costs in the management of small cell lung cancer. Thorax, 56 (10). pp. 785-790. ISSN 0040-6376
Conference or Workshop Item
Shaw, N., Alldred, D. orcid.org/0000-0002-2525-4854, Anderson, A. et al. (4 more authors) (2024) P379 “Now I have a future”: adult perspectives and experiences of health status and adherence post CFTR modulator therapy. In: 47th European Cystic Fibrosis Conference, 05-08 Jun 2024, Glasgow, UK.
Shaw, N. orcid.org/0000-0003-3221-2588, Alldred, D., Anderson, A. et al. (4 more authors) (2023) Medication burden among adults with cystic fibrosis prescribed CFTR Modulators: a cross-sectional survey. In: 46th European Cystic Fibrosis Society Conference, 07-10 Jun 2023, Vienna.
Shaw, N. orcid.org/0000-0003-3221-2588, Alldred, D. orcid.org/0000-0002-2525-4854, Anderson, A. et al. (4 more authors) (2023) WS11.05 Medication burden among adults with cystic fibrosis prescribed CFTR Modulators: a cross-sectional survey. In: 46th European Cystic Fibrosis Conference, 07-10 Jun 2023, Vienna, Austria.